Par Drugs & Chemical

204.85
-0.55
(-0.27%)
Market Cap (₹ Cr.)
₹253
52 Week High
348.45
Book Value
₹
52 Week Low
190.15
PE Ratio
13.83
PB Ratio
2.61
PE for Sector
37.26
PB for Sector
4.92
ROE
15.91 %
ROCE
22.01 %
Dividend Yield
0.00 %
EPS
₹11.84
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-0.10 %
Net Income Growth
28.32 %
Cash Flow Change
51.35 %
ROE
6.41 %
ROCE
8.32 %
EBITDA Margin (Avg.)
25.13 %

Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
11
17
16
16
17
20
17
22
24
25
23
25
23
26
24
23
23
36
Expenses
8
12
12
12
12
16
13
18
20
19
20
19
19
19
19
17
18
23
EBITDA
3
5
4
4
4
4
4
5
4
6
3
5
4
7
6
6
4
12
Operating Profit %
24 %
30 %
24 %
27 %
25 %
21 %
21 %
20 %
16 %
24 %
14 %
22 %
18 %
28 %
22 %
27 %
19 %
33 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
2
4
3
3
3
3
3
4
3
5
3
5
3
7
5
5
3
12
Tax
0
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
3
Net Profit
2
4
2
2
3
2
2
2
2
4
2
4
3
5
3
4
3
9
EPS in ₹
2.61
5.70
3.39
3.95
2.00
1.80
1.80
1.97
1.86
3.03
1.52
2.80
2.01
3.97
2.78
3.02
2.06
6.99

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
56
54
51
60
76
79
89
102
Fixed Assets
42
39
36
34
30
34
38
41
Current Assets
14
14
14
24
41
44
49
60
Capital Work in Progress
0
0
0
1
5
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
15
15
15
25
42
44
50
60
Total Liabilities
56
54
51
60
76
79
89
102
Current Liabilities
20
17
13
11
16
15
14
12
Non Current Liabilities
17
16
10
9
8
4
4
4
Total Equity
20
21
29
41
52
60
71
86
Reserve & Surplus
11
13
25
35
46
48
59
73
Share Capital
9
9
5
6
6
12
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-1
0
0
7
14
-5
6
14
Investing Activities
-0
-0
-2
-1
-0
-2
0
-3
-7
-6
Operating Activities
9
7
9
4
2
8
12
8
13
20
Financing Activities
-9
-6
-8
-4
-2
1
2
-10
0
0

Share Holding

% Holding
Mar 2021
Apr 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
73.86 %
73.86 %
73.86 %
73.98 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
73.37 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.02 %
23.73 %
20.92 %
21.55 %
21.48 %
21.29 %
21.55 %
21.98 %
22.05 %
21.85 %
21.40 %
21.23 %
20.46 %
20.09 %
19.42 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,841.35 4,36,439.00 38.90 49,887.20 12.06 9,648 27.34 59.05
5,886.75 1,53,503.20 83.63 8,184.00 0.89 1,600 46.55 48.08
1,490.55 1,19,175.70 25.82 26,520.70 14.17 4,155 12.95 50.71
2,916.65 1,16,611.50 56.78 10,615.60 19.57 1,942 28.89 63.62
1,355.15 1,12,712.30 21.12 28,905.40 12.36 5,578 -9.47 71.05
2,182.10 98,956.70 37.66 20,141.50 19.94 1,936 73.53 60.05
957.65 97,081.50 22.69 19,831.50 13.82 3,831 14.57 42.02
1,256.25 73,323.30 20.28 29,559.20 17.55 3,169 8.66 48.45
5,408.60 64,640.40 29.75 12,978.40 9.84 1,812 14.16 41.69
1,541.45 43,338.50 - 12,653.10 6.58 -1,831 675.49 48.19

Corporate Action

Technical Indicators

RSI(14)
Neutral
36.41
ATR(14)
Less Volatile
15.43
STOCH(9,6)
Neutral
21.65
STOCH RSI(14)
Neutral
27.50
MACD(12,26)
Bearish
-2.26
ADX(14)
Weak Trend
20.05
UO(9)
Bearish
38.31
ROC(12)
Downtrend But Slowing Down
-10.29
WillR(14)
Oversold
-88.45